Document Detail


Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study.
MedLine Citation:
PMID:  15653258     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Based upon pharmacological challenge and postmortem studies, schizophrenia has been hypothesized to be caused by decreased glutamatergic neurotransmission. We investigated the glutamatergic neuronal metabolism of the dorsolateral prefrontal cortex with localized 1H magnetic resonance spectroscopy in 18 first-episode patients, 21 chronic patients with schizophrenia, and 21 age-matched controls. Chronic patients had significantly lower levels of glutamate/glutamine (Glx) and N-acetylaspartate (NAA) compared to healthy controls and first-episode patients. Reduced metabolite levels were not correlated with duration of illness or medication. Our results indicate glutamatergic dysfunction in chronic schizophrenia that could be evidence of a progressive brain disorder.
Authors:
Patricia Ohrmann; Ansgar Siegmund; Thomas Suslow; Katharina Spitzberg; Anette Kersting; Volker Arolt; Walter Heindel; Bettina Pfleiderer
Related Documents :
15352928 - Pleasurable auditory hallucinations.
14972368 - Cerebral ventricular change over the first 10 years after the onset of schizophrenia.
10375148 - Psychopathy and violent behavior among patients with schizophrenia or schizoaffective d...
18206248 - A two-factor structure for the schedule for the deficit syndrome in schizophrenia.
17964008 - Three month intervention with protein and energy rich supplements improve muscle functi...
3698238 - Clinical and electrophysiologic characterization of automatic junctional tachycardia in...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Schizophrenia research     Volume:  73     ISSN:  0920-9964     ISO Abbreviation:  Schizophr. Res.     Publication Date:  2005 Mar 
Date Detail:
Created Date:  2005-01-17     Completed Date:  2005-06-09     Revised Date:  2010-09-02    
Medline Journal Info:
Nlm Unique ID:  8804207     Medline TA:  Schizophr Res     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  153-7     Citation Subset:  IM    
Affiliation:
University of Muenster, Department of Psychiatry, Albert-Schweitzer-Str. 11, Germany. ohrmann@uni-muenster.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aspartic Acid / analogs & derivatives*,  metabolism*
Chronic Disease
Diagnostic and Statistical Manual of Mental Disorders
Female
Glutamic Acid / metabolism*
Glutamine / metabolism*
Humans
Magnetic Resonance Spectroscopy*
Male
Neurons / metabolism,  physiology*
Prefrontal Cortex / metabolism*,  physiopathology*
Protons / diagnostic use*
Schizophrenia / diagnosis,  metabolism*,  physiopathology*
Schizophrenic Psychology
Severity of Illness Index
Synaptic Transmission / physiology*
Chemical
Reg. No./Substance:
0/Protons; 56-84-8/Aspartic Acid; 56-85-9/Glutamine; 56-86-0/Glutamic Acid; 997-55-7/N-acetylaspartate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-a...
Next Document:  Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: f...